PUREfi Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
2,108
+17
+0.8% +$17.4K 1.39% 14
2026
Q1
$1.92M Sell
2,091
-107
-5% -$108K 1.26% 16
2025
Q4
$2.36M Sell
2,198
-243
-10% -$232K 1.81% 11
2025
Q3
$1.86M Buy
2,441
+251
+11% +$187K 1.43% 13
2025
Q2
$1.71M Buy
2,190
+905
+70% +$703K 1.36% 13
2025
Q1
$1.06M Buy
1,285
+580
+82% +$483K 1.06% 15
2024
Q4
$544K Buy
+705
New +$584K 0.53% 45

Other funds holding LLY

PUREfi Wealth's LLY Position: Q2 2026 in Review

PUREfi Wealth increased its Eli Lilly (LLY) stake by 0.81% in Q2 2026, buying an estimated $17.4K and bringing the position to 2,108 shares worth $2.53M. The position accounts for 1.39% of the portfolio, ranked #14.

PUREfi Wealth first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PUREfi Wealth held 2,108 shares of Eli Lilly worth $2.53M as of Q2 2026.
  • PUREfi Wealth bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 1.39% of PUREfi Wealth's portfolio in Q2 2026, its #14 holding.
  • PUREfi Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PUREfi Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.